Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial

Author： Elgadi Mabrouk M.

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.11, Iss.4, 2011-12, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ritonavir-boosted darunavir: a powerful option for treatment-experienced HIV-1-infected patients

By Menééndez-Arias Luis Matamoros Tania ÁÁlvarez Mar

Future Virology, Vol. 3, Iss. 5, 2008-09 ,pp. : 423-434

Future Medicine

Access to resources Recommend Favorite

Darunavir: In Treatment-Experienced Pediatric Patients with HIV-1 Infection

By McKeage Kate Scott Lesley J.

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 123-131

Adis International

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen Morelló Judit Garcia-Gascó Pilar Rodríguez-Novoa Sonia Soriano Vincent

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Bevirimat beneficial for treatment-experienced patients with HIV

Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Darunavir: a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection

By Robertson Jaime Feinberg Judith

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1363-1375

Informa Healthcare

Access to resources Recommend Favorite